FDA Inspection
Department of the ArmyDepartment of the Army – FDA Inspection, Jul 14, 2026
Record Details
This FDA Inspection record concerns Department of the Army, with an inspection on July 14, 2026, issued by the Atlanta District Office, covering biologics.
View Company Profile
ID · 10b46e8c-3b04-4a05-9299-9a848ce5563d
Inspection Facts
- Inspection number
- 1326264
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 600.14(a)(1)Who must report - receiving information
- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
- 21 CFR 630.40(b)(3)Results of testing
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Department of the Army
6| Date | Classification | Office | Project area |
|---|---|---|---|
| April 28, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 30, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 18, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 6, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 9, 2010 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Department of the Army
- FDA Inspection 1206237 - 2023-04-28
- FDA Inspection 1068671 - 2018-08-30
- FDA Inspection 930175 - 2015-06-18
- FDA Inspection 809470 - 2012-12-06
- FDA Inspection 701132 - 2010-12-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.